Morphological abnormalities of lymphocytes from patients with advanced solid tumours

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Patients with advanced solid tumors often exhibit altered immune cell morphology.
• Lymphocyte surface characteristics can be indicative of disease state.
• Understanding these changes may offer insights into cancer progression and immune response.

Purpose of the Study:

• To investigate the characteristic morphological abnormalities of lymphocytes in patients with advanced solid tumors.
• To determine if cancer serum influences lymphocyte surface morphology.
• To assess the effect of an immunostimulant on lymphocyte surface projections in cancer patients.

Main Methods:

• Comparative morphological analysis of peripheral blood lymphocytes from cancer patients and healthy controls.
• In vitro incubation of normal lymphocytes with cancer patient serum.
• In vitro incubation of normal lymphocytes with normal heterologous serum.
• Incubation of cancer lymphocytes with levamisole.

Main Results:

• Lymphocytes from cancer patients displayed numerous surface microprojections, unlike smoother lymphocytes from controls.
• Incubation of normal lymphocytes in cancer serum led to increased microprojection formation.
• Incubation in normal serum did not alter normal lymphocyte surface morphology.
• Levamisole treatment did not reduce surface projections on cancer lymphocytes.

Conclusions:

• Advanced solid tumors are associated with distinct lymphocyte surface abnormalities (microprojections).
• Cancer serum appears to induce these microprojections on normal lymphocytes, indicating a potential serum-mediated effect.
• The observed surface changes are not reversed by levamisole, suggesting complex underlying mechanisms.